Cargando…

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review

INTRODUCTION: The treatment of type 2 diabetes mellitus (T2DM) continues to pose challenges for clinicians and patients. The dramatic rise in T2DM prevalence, which has paralleled the rise in obesity, has strained the healthcare system and prompted the search for therapies that not only effectively...

Descripción completa

Detalles Bibliográficos
Autor principal: McGill, Janet B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065283/
https://www.ncbi.nlm.nih.gov/pubmed/24729157
http://dx.doi.org/10.1007/s13300-014-0063-1

Ejemplares similares